The data reveals that Italy, Indonesia, and Slovenia lead in global share of top-cited endocrinology, diabetes, and metabolism publications, with Italy at the forefront with a 23.51% share. The United States and China, though significant producers of scientific research, are positioned lower than expected with shares around 12.4% and 12.37% respectively. In contrast, emerging countries like Vietnam and Latvia are showcasing strong performances. The trends over previous years reveal minimal variations, indicating a stable or slightly declining landscape for key players.
Future trends to watch include the rise of non-traditional leaders like Indonesia and Slovenia, growing their research influence. It's important to consider how the evolving global research landscape, driven by collaborations, technological advancements, and strategic funding in specific niches, will influence shares in scientific outputs. Potential geopolitical and economic shifts may also redefine this dynamic in the coming years.
Top countries in Share of Scientific Publications Among the World's 10% Top-Cited Publications in Endocrinology, Diabetes and Metabolism by Country
| # | 10 Countries | Percent | Last Year | |
|---|---|---|---|---|
| 1 | 1 Italy | 23.51 | 2023 | View data |
| 2 | 2 Indonesia | 20.76 | 2023 | View data |
| 3 | 3 Slovenia | 19.35 | 2023 | View data |
| 4 | 4 Vietnam | 18.14 | 2023 | View data |
| 5 | 5 Latvia | 16.78 | 2023 | View data |
| 6 | 6 Sweden | 16.3 | 2023 | View data |
| 7 | 7 Netherlands | 16.25 | 2023 | View data |
| 8 | 8 Argentina | 15.74 | 2023 | View data |
| 9 | 9 Finland | 14.29 | 2023 | View data |
| 10 | 10 United Kingdom | 14.18 | 2023 | View data |
